Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2021-09-01 2021-09-01
Drug Identification Number 01926438 01926438
Brand name KIDROLASE KIDROLASE
Common or Proper name L-asparaginase powder for solution L-asparaginase powder for solution
Company Name JAZZ PHARMACEUTICALS FRANCE SAS JAZZ PHARMACEUTICALS FRANCE SAS
Ingredients ASPARAGINASE ASPARAGINASE
Strength(s) 10000UNIT 10000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1 vial/pack 1 vial/pack
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date 2020-11-10 2020-11-10
Actual discontinuation date 2021-06-30 2021-06-30
Remaining supply date 2020-02-29 2020-02-29
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments